# CVS HEALTH CORPORATION (CVS) FY2024 Q1 P&L / Income Statement

- Company: CVS HEALTH CORPORATION (CVS)
- Period: 2024-01-01 to 2024-03-31
- Filing: Q1 FY2024 10-Q, filed 2024-05-01, accession number 0000064803-24-000016
- Page: https://plicit.ai/financials/cvs/fy2024-q1-income-statement
- Chart image: https://plicit.ai/charts/cvs-fy2024-q1-income-statement-sankey.png

## Chart details: Revenue by Product and Service

Income statement for 2024-01-01 through 2024-03-31. View: Revenue categories. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 88,437,000,000 US dollars
- **Total operating costs**: 86,166,000,000 US dollars
- **Operating income**: 2,271,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 691,000,000 US dollars
- **Income before income tax provision**: 1,580,000,000 US dollars
- **Income tax provision**: 456,000,000 US dollars
- **Net income**: 1,124,000,000 US dollars
- **Products**: 53,724,000,000 US dollars
- **Services**: 3,868,000,000 US dollars
- **Premiums**: 30,391,000,000 US dollars
- **Net investment income**: 454,000,000 US dollars
- **Cost of products sold**: 48,073,000,000 US dollars
- **Health care costs**: 27,803,000,000 US dollars
- **Loss on assets held for sale**: 0 US dollars
- **Operating expenses**: 10,290,000,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Of which attributable to CVS HEALTH CORPORATION: $1.11 B; to noncontrolling interests: $11.00 M.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/cvs/fy2024-q1-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/cvs-fy2024-q1-revenue-by-business-segment-sankey.png

Income statement for 2024-01-01 through 2024-03-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Total revenues**: 88,437,000,000 US dollars
- **Total operating costs**: 86,166,000,000 US dollars
- **Operating income**: 2,271,000,000 US dollars
- **Other income (expense), net (calculated)**: negative 691,000,000 US dollars
- **Income before income tax provision**: 1,580,000,000 US dollars
- **Income tax provision**: 456,000,000 US dollars
- **Net income**: 1,124,000,000 US dollars
- **Health Care Benefits**: 32,236,000,000 US dollars
- **Health Services**: 40,285,000,000 US dollars
- **Pharmacy & Consumer Wellness**: 28,725,000,000 US dollars
- **Cost of products sold**: 48,073,000,000 US dollars
- **Health care costs**: 27,803,000,000 US dollars
- **Loss on assets held for sale**: 0 US dollars
- **Operating expenses**: 10,290,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 101,246,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Intersegment Eliminations**: negative 12,924,000,000 US dollars. Reported reconciliation to consolidated revenue.
- **Corporate/ Other**: 115,000,000 US dollars. Reported reconciliation to consolidated revenue.

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.
- Of which attributable to CVS HEALTH CORPORATION: $1.11 B; to noncontrolling interests: $11.00 M.